Smith & Nephew SNATS Inc. - ADR Share Price Today, Stock Analysis, Annual Report | Value Research Smith & Nephew SNATS Inc. - ADR - Get live share price today, stock analysis, price valuation, performance, fundamentals, market cap, share holding, financial report of US stocks.

Smith & Nephew SNATS Inc. - ADR

Download Stock Report

NYSE: SNN

  • Price Change
  • Market Capitalisation market-capitalisation-info $14,139 Mln

  • 12 Month Earnings monthly-earning $--
  • Price to Earnings price-to-earning 62.49

Smith & Nephew SNATS Inc. - ADR Share Price

$25.36

As on 22-Sep-2023 16:10 EDT

up-down-arrow $-0.06-0.24%

  • Prev Close info

    $25.42

  • Day's Openinfo

    $25.44

  • Today's Highinfo

    $25.54

  • Today's Lowinfo

    $25.33

  • Today's Volumeinfo

    1,035,584

Please wait...

Smith & Nephew SNATS Inc. - ADR Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Smith & Nephew SNATS - ADR
-5.69 -7.21 -19.06 9.74 -12.30 -7.22 0.21
S&P BSE Sensex
8.49 1.22 3.91 11.02 20.17 12.37 12.54
#
-- -- -- -- -- -- --
As on 22-Sep-2023  |  #As on
2022
2021
2020
2019
2018
2017
2016
Smith & Nephew SNATS - ADR
-22.33 -16.21 -10.40 30.84 8.85 18.57 -13.93
S&P BSE Sensex
4.44 21.99 15.75 14.38 5.87 27.91 1.95
S&P BSE Sensex
4.44 21.99 15.75 14.38 5.87 27.91 1.95

Valuation

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Smith & Nephew SNATS Inc. - ADR Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of Smith & Nephew SNATS Inc. - ADR

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        CFO & Exec. Director

        Ms. Anne-Francoise Nesmes

        CEO & Director

        Dr. Deepak S. Nath Ph.D.

        Headquarters

        Watford

        FAQs for Smith & Nephew SNATS Inc. - ADR

        The total asset value of Smith & Nephew SNATS Inc. - ADR stood at $ 9,966 Mln as on 31-Dec-22

        The share price of Smith & Nephew SNATS Inc. - ADR is $25.360000 (NYSE) as of 22-Sep-2023 16:10 EDT. Smith & Nephew SNATS Inc. - ADR has given a return of -12.3% in the last 3 years.

        Smith & Nephew SNATS Inc. - ADR has a market capitalisation of $ 14,139 Mln as on 19-May-2023. As per Value Research classification, it is a company.

        The P/B ratio of Smith & Nephew SNATS Inc. - ADR is 2.25 times as on 19-May-2023, a -0.44% premium to its peers’ median range of 4.02 times.

        The P/E ratio of Smith & Nephew SNATS Inc. - ADR is 62.49 times as on 19-May-2023, a -0.7% premium to its peers’ median range of 207.27 times.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the Smith & Nephew SNATS Inc. - ADR and enter the required number of quantities and click on buy to purchase the shares of Smith & Nephew SNATS Inc. - ADR.

        Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. The company operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products, including instruments, technologies, and implants to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

        The CEO & director of Ms. Anne-Francoise Nesmes. is Smith & Nephew SNATS Inc. - ADR, and CFO & Sr. VP is Dr. Deepak S. Nath Ph.D..

        The promoters of Smith & Nephew SNATS Inc. - ADR have pledged 0% of the total equity as on Mar-23.

        Smith & Nephew SNATS Inc. - ADR Ratios
        Return on equity(%)
        4.12
        Return on capital employed(%)
        2.62
        Debt-to-equity ratio
        0.55
        Dividend yield(%)
        --

        No, TTM profit after tax of Smith & Nephew SNATS Inc. - ADR was No Profit.

        Edit peer-selector-edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap market-cap-information $14,139.13 Mln
        • Revenue (TTM)revenue-information $--
        • Earnings (TTM) earning-information $--
        • Cash date-information $0.00 Mln
        • Total Debt info $--
        • Insider's Holding 0.05%
        • Liquidity liquidity High
        • 52 Week range week-range $21.78 - 33.09
        • Shares outstanding share-outstanding 436,686,016
        • 10 Years Aggregate:

          CFO: $8,898.00 Mln

          EBITDA: $12,532.00 Mln

          Net Profit: $5,476.00 Mln

        About The Company

        • IPO Date 16-Nov-1999
        • CFO & Exec. Director Ms. Anne-Francoise Nesmes
        • CEO & Director Dr. Deepak S. Nath Ph.D.
        • Listing key-listing NYSE: SNN
        • Country United Kingdom
        • Headquarters headquarters Watford
        • Website website https://www.smith-nephew.com
        • Business

          Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. The company operates through three segments: Orthopaedics, Sports Medicine & ENT,...  and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products, including instruments, technologies, and implants to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.  Read more

        Demystifying Stocks.

        At Value Research, we believe it's best to understand investments before diving in. And since 1990, we've been doing exactly that – helping & guiding lakhs of Indians with their investing journey. Join the journey.

        Sign Up for Free
        demystifying-mutual-fund

        What can Value Research do for you?

        solidify-your-fundamentals
        Solidify your fundamentals

        Learn the principles, mindset and tools you need to become a successful Mutual Fund and Stock investor from the masters who have been doing this for decades.

        track-all-your-investments
        Track all your investments

        Use India's most advanced investment tracker to track, analyse and get updates and insights on your investments.

        get-guidance-from-our-experts
        Get guidance from our experts

        Get an analysis of your portfolio along with actionable, general tips and insights, guidance on where to invest based on your goals, and experts' opinions on individual Mutual Funds and Stocks.

        get-access-to-exclusive-analytics
        Get access to exclusive analytics

        Value Research offers the most advanced and detailed data & analytics available on Mutual Funds and Stocks. Sign up and unlock the power yourself.

        Explore it yourself, for free

        Sign up and get access to:

        Unlimited access to advice from India's top experts

        The most comprehensive analysis of funds and stocks in India

        A holistic portfolio manager to help track all your investments easily

        And much more, like guides, tools, webinars, videos and eBooks.

        share-fund-plan-icon